Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops...
35 insider purchases on record · latest filing 2026-04-07.
Insiders have also filed 14 sale transactions at LPCN.